tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RHHBY Stock Latest News

Roche upgraded to Neutral from Underweight at JPMorgan
The FlyRoche upgraded to Neutral from Underweight at JPMorgan
7h ago
CHRO
Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’
PremiumThe Fly
Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’
3d ago
F
GM
FDA shift in drug study requirements sends trial runners lower
PremiumThe Fly
FDA shift in drug study requirements sends trial runners lower
4d ago
AZN
BMY
FDA to reduce number of trials required for drug approvals, STAT reports
PremiumThe Fly
FDA to reduce number of trials required for drug approvals, STAT reports
4d ago
AZN
BMY
FDA to reduce number of trials required for drug approvals, STAT reports
PremiumThe Fly
FDA to reduce number of trials required for drug approvals, STAT reports
4d ago
AZN
BMY
Is AstraZeneca’s Stock (AZN) a Good Investment Right Now?
PremiumMarket NewsIs AstraZeneca’s Stock (AZN) a Good Investment Right Now?
6d ago
AZN
BMY
Roche price target raised to CHF 290 from CHF 255 at Morgan Stanley
Premium
The Fly
Roche price target raised to CHF 290 from CHF 255 at Morgan Stanley
6d ago
CHRO
Roche price target raised to CHF 300 from CHF 290 at Berenberg
Premium
The Fly
Roche price target raised to CHF 300 from CHF 290 at Berenberg
6d ago
CHRO
Top drug regulator Richard Pazdur preparing to exit FDA, STAT News reports
PremiumThe Fly
Top drug regulator Richard Pazdur preparing to exit FDA, STAT News reports
6d ago
AZN
BMY
Vaccine committee considers changes to childhood schedule, NY Times reports
PremiumThe Fly
Vaccine committee considers changes to childhood schedule, NY Times reports
6d ago
AZN
BMY
Roche receives FDA clearance with CLIA waiver for pertussis point-of-care test
PremiumThe Fly
Roche receives FDA clearance with CLIA waiver for pertussis point-of-care test
6d ago
CHRO
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
PremiumThe Fly
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
7d ago
B
BX
Trump Trade: U.S. confirms agreement with U.K. on pharmaceutical pricing
PremiumThe FlyTrump Trade: U.S. confirms agreement with U.K. on pharmaceutical pricing
7d ago
AZN
BMY
US government confirms agreement in principle with UK on pharmaceutical pricing
Premium
The Fly
US government confirms agreement in principle with UK on pharmaceutical pricing
7d ago
AZN
BMY
US, UK expected to agree on zero-tariffs pharmaecuticals deal, UK Times says
Premium
The Fly
US, UK expected to agree on zero-tariffs pharmaecuticals deal, UK Times says
7d ago
AZN
BMY
Oppenheimer says Roche’s commitment to Veeva Vault CRM carries greater weight
PremiumThe Fly
Oppenheimer says Roche’s commitment to Veeva Vault CRM carries greater weight
14d ago
CHRO
VEEV
Lineage Cell says first OpRegen development milestone under Roche pact achieved
PremiumThe Fly
Lineage Cell says first OpRegen development milestone under Roche pact achieved
14d ago
CHRO
LCTX
Lineage Cell’s OpRegen shows evidence of progress, says H.C. Wainwright
PremiumThe Fly
Lineage Cell’s OpRegen shows evidence of progress, says H.C. Wainwright
14d ago
CHRO
LCTX
Prothena price target raised to $8 from $4 at BofA
PremiumThe Fly
Prothena price target raised to $8 from $4 at BofA
14d ago
NVO
CHRO
Veeva announces expanded partnership with Roche Pharmaceuticals
PremiumThe FlyVeeva announces expanded partnership with Roche Pharmaceuticals
14d ago
CHRO
VEEV
Olema Oncology price target raised to $40 from $20 at Guggenheim
Premium
The Fly
Olema Oncology price target raised to $40 from $20 at Guggenheim
18d ago
CHRO
OLMA
Roche announces EC granted conditional marketing approval of Lunsumio SC
Premium
The Fly
Roche announces EC granted conditional marketing approval of Lunsumio SC
19d ago
CHRO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >